 treatment fulmin hepat failur insulin glucagon random control trial insulin glucagon therapeut modal treatment fulmin hepat failur fhf random trial insulin glucagon patient fhf viral toxin exposur control treatment group patient etiolog admiss laboratori valu mortal differ control treatment group time random death discharg differ group peak level alpha-fetoprotein survivor nonsurvivor error combin insulin glucagon use treatment fhf